glp-1 agonists medications New Guidelines for Type 2 Diabetes in 2025 GLP-1 Costs Explained: Managing Coverage

Description

Hepatotoxicity of alogliptin

GLP-1 Agonists: Optimizing Therapy Across Clinical Scenarios (1.5 hours) CE/CME Course #: 25-396 Review clinical guidance on optimizing use of GLP-1 receptor agonists (RAs) for managing type 2 diabetes and weight loss, as well as their role in cardiovascular and kidney diseases

Not for use in patients with type 1 diabetes or diabetic ketoacidosis

And they must be refrigerated until use

406 Therefore, endogenous GLP-1R signaling in astrocytes plays a critical role in maintaining mitochondrial homeostasis and is dependent on FGF21 to effectively regulate glucose metabolism